Lamivudine and Right ventricular failure - a phase IV clinical study of FDA data

Summary:

Right ventricular failure is reported as a side effect among people who take Lamivudine (lamivudine; zidovudine; nevirapine), especially for people who are male, 30-39 old, also take Hepsera, and have Hepatitis b antibody positive.

The phase IV clinical study analyzes which people have Right ventricular failure when taking Lamivudine. It is created by eHealthMe based on reports of 17,197 people who have side effects when taking Lamivudine from the FDA, and is updated regularly.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,242 Lamivudine users. Check the latest studies of Lamivudine.

What is Right ventricular failure?

Right ventricular failure (right half of the heart fails to work) is found to be associated with 589 drugs and 718 conditions by eHealthMe. Check the latest studies of Right ventricular failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

17,197 people reported to have side effects when taking Lamivudine.
Among them, 11 people (0.06%) have Right ventricular failure.

Could Lamivudine cause Right ventricular failure?

Among these 11 people:

What is the gender of people who have Right ventricular failure when taking Lamivudine? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Right ventricular failure when taking Lamivudine? *

What are other drugs people take besides Lamivudine? *

What are other side effects people have besides Right ventricular failure? *

Hypotension (abnormally low blood pressure): 4 people, 36.36%
Abdominal Distension: 3 people, 27.27%
Nausea And Vomiting: 3 people, 27.27%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 27.27%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 27.27%
Consciousness - Decreased: 3 people, 27.27%
Blood Creatine Phosphokinase Mb Increased: 3 people, 27.27%
Blood Creatine Phosphokinase Increased: 3 people, 27.27%
Lactic Acidosis (low ph in body tissues): 3 people, 27.27%
Liver Disorder (liver diseases): 3 people, 27.27%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 9.09%
Hepatitis B Antibody Positive: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lamivudine and have Right ventricular failure?

- Check whether Right ventricular failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamivudine:

Lamivudine (17,242 reports)

Right ventricular failure treatments and more:

Right ventricular failure (10,162 reports)

How severe was Right ventricular failure and when was it recovered:

Right ventricular failure in Lamivudine

Expand to all the drugs that have ingredients of lamivudine; zidovudine; nevirapine:

Right ventricular failure and drugs with ingredients of lamivudine; zidovudine; nevirapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamivudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Right ventricular failure:

Right ventricular failure (589 drugs)

Browse all the conditions that are associated with Right ventricular failure:

Right ventricular failure (718 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine; nevirapine (the active ingredients of Lamivudine) and Lamivudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.